No headlines found.
Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update
PRNewswire (Mon, 11-Mar 9:00 AM ET)
Cadrenal Therapeutics to Participate at Technology and Heart Failure Therapeutics (THT) Conference
PRNewswire (Mon, 26-Feb 9:00 AM ET)
PRNewswire (Thu, 8-Feb 9:00 AM ET)
PRNewswire (Wed, 31-Jan 9:00 AM ET)
PRNewswire (Wed, 24-Jan 9:00 AM ET)
PRNewswire (Thu, 4-Jan 9:00 AM ET)
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
Cadrenal Therapeutics trades on the NASDAQ stock market under the symbol CVKD.
As of March 27, 2024, CVKD stock price declined to $0.64 with 45,955 million shares trading.
CVKD has a beta of 1.52, meaning it tends to be more sensitive to market movements. CVKD has a correlation of 0.03 to the broad based SPY ETF.
CVKD has a market cap of $10.25 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that CVKD belongs to (by Net Assets): VXF.
CVKD stock has underperformed the market in the last year with a return of -48.8%, while SPY returned +33.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CVKD shares. However, CVKD has outperformed the market in the last 3 month and 2 week periods, returning +16.4% and +10.3%, while SPY returned +10.3% and +1.5%, respectively. This indicates CVKD has been having a stronger performance recently.
CVKD support price is $.60 and resistance is $.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVKD stock will trade within this expected range on the day.